Side of LogoAETC National Resource Center HomeSide of LogoTop of Banner
Search Web site
spacespaceClinical Manual > Pain and Palliative > Palliative Care and HIV
space
space

Palliative Care and HIV

July 2006


Chapter Contents

Background

Subjective

Objective

Assessment and Plan

Patient Education

References

Table 1. Common Symptoms in Patients with AIDS and Possible Disease-Specific and Palliative Interventions

space

Background

Palliative care is not curative care, but is supportive, symptom-oriented care. It is usually needed throughout the course of disease progression to relieve patients' suffering and promote quality of life. Palliative care is important for patients with any medical condition. It may be used in conjunction with disease-specific care or as the sole approach to care. Palliative care includes the following:

  • Management of symptoms (eg, fatigue, pain)
  • Treatment of adverse effects (eg, nausea, vomiting)
  • Psychosocial support (eg, depression, advance care planning)
  • End-of-life care

Following is the widely used definition of palliative care according to the World Health Organization:

    Palliative medicine is the study and management of patients with active, progressive, far advanced disease for whom the prognosis is limited and the focus of care is the quality of life. [It is] the active total care of patients whose disease is not responsive to curative treatment. Control of pain, of other symptoms, and of psychological, social, and spiritual problems, is paramount. The goal of palliative care is achievement of the best quality of life for patients and their families.

Palliative care in AIDS patients comprises a continuum of treatment consisting of therapy directed at AIDS-related illnesses (eg, infection or malignancy) and treatments focused on providing comfort and symptom control throughout the life span. This care may involve multidimensional and multidisciplinary services, including HIV medicine, nursing, pharmacy, social work, complementary/alternative medicine, and physical therapy.

Palliative Care in the Era of Antiretroviral Therapy

With advances in HIV-specific therapy and care, HIV infection is no longer a rapidly fatal illness. Instead, those patients who are able to tolerate antiretroviral therapy (ART) often experience a manageable, chronic illness.

The death rate from AIDS, however, continues to be significant: approximately 15,000-16,000 per year in the United States. In many parts of the world, patients are not able to obtain specific treatments for HIV or for opportunistic illnesses, and supportive or palliative care may be the primary mode of care available to patients with advanced AIDS. Regardless of access to disease-specific treatment, people living with HIV continue to experience symptoms from HIV disease and its comorbid conditions, and those taking ART may experience adverse effects. Integrating palliative care with disease-specific care is important in the treatment of patients with HIV to promote quality of life and to relieve suffering.

S: Subjective

The patient with advanced HIV disease complains of 1 or more of the following:

  • Agitation
  • Anorexia
  • Chronic pain
  • Constipation
  • Cough
  • Decubitus ulcers or pressure sores
  • Delirium
  • Dementia
  • Depression
  • Diarrhea
  • Dry skin
  • Dyspnea
  • Fatigue
  • Fever
  • Increased secretions ("death rattle")
  • Nausea
  • Pruritus
  • Sweats
  • Vomiting
  • Weakness
  • Weight loss

O: Objective

Conduct a complete symptom-directed physical examination.

A: Assessment and Plan

Treatment

Table 1 lists common symptoms of AIDS and their possible causes. Also included are disease-specific treatments and palliative interventions. Depending on the situation, either or both of these treatments may be appropriate. Consider the patient's disease stage and symptom burden, the risks and benefits of therapies, and the patient's wishes. Practitioners should note that some of the palliative treatments may have substantial long-term adverse effects and should be used to alleviate symptoms only in late-stage or dying patients.

Table 1. Common Symptoms in Patients with AIDS and Possible Disease-Specific and Palliative Interventions

SymptomPossible CausesDisease-Specific or Curative TreatmentPalliative Treatment*

Key to abbreviations: OIs = opportunistic infections; ART = antiretroviral therapy; MAC = Mycobacterium avium complex; NSAIDs = nonsteroidal antiinflammatory drugs; CMV = cytomegalovirus; VZV = varicella zoster virus; PCP = Pneumocystis jiroveci pneumonia; TB = tuberculosis; SSRI = selective serotonin reuptake inhibitor.

* Some of the palliative treatments may have substantial long-term adverse effects and should be used to alleviate symptoms only in late-stage or dying patients.

Adapted with permission from Selwyn PA, Rivard M. Palliative care for AIDS: Challenges and opportunities in the era of highly active anti-retroviral therapy. Innovations in End-of-Life Care. 2002;4(3), Available at www.edc.org/lastacts .

CONSTITUTIONAL
Fatigue, weakness
  • AIDS
  • OIs
  • Anemia
  • ART
  • Treat specific infections
  • Erythropoietin, transfusion
  • Psychostimulants (methylphenidate, pemoline, dextroamphetamine, modafinil)
  • Testosterone/androgens
  • Corticosteroids (prednisone, dexamethasone)
Weight loss/anorexia
  • HIV
  • Malignancy
  • ART
  • Chemotherapy
  • Nutritional support/enteral feedings
  • Testosterone/androgens
  • Oxandrolone
  • Megestrol acetate
  • Dronabinol
  • Recombinant growth hormone
  • Corticosteroids
Fevers, sweats
  • Disseminated MAC and other infections
  • HIV lymphoma, and other malignancies
  • Specific treatment of OIs or malignancy
  • ART
  • NSAIDs (ibuprofen, naproxen, indomethacin)
  • Anticholinergics (hyoscine, thioridazine)
  • H2-antagonists (cimetidine)
PAIN
Nociceptive, somatic, visceral
  • Opportunistic infections
  • HIV-related malignancies, nonspecific
  • Specific treatment of disease entities
  • NSAIDs
  • Opioids
  • Corticosteroids
Neuropathic
  • HIV-related peripheral neuropathy
  • CMV
  • VZV
  • Medications (eg, dideoxynucleosides: didanosine, zalcitabine, stavudine), isoniazid, vincristine
  • ART
  • Discontinue offending medication;
  • Change antiretroviral or other regimen
  • NSAIDs
  • Neuropathic pain medications:
    • tricyclics (amitriptyline, imipramine)
    • benzodiazepines (clonazepam)
    • anticonvulsants (gabapentin, lamotrigine)
  • Opioids (eg, methadone) and adjuvants
  • Corticosteroids
  • Acupuncture
GASTROINTESTINAL
Nausea, vomiting
  • Antiretroviral medications
  • Esophageal candidiasis
  • CMV
  • Specific treatment of disease entities
  • Change antiretroviral regimen
  • Dopamine antagonists (prochlorperazine, haloperidol)
  • Prokinetic agents (metoclopramide)
  • Antihistamines (diphenhydramine, promethazine)
  • Anticholinergics (hyoscine, scopolamine)
  • Serotonin antagonists (granisetron, ondansetron, dolasetron)
  • H2 blockers (cimetidine)
  • Proton pump inhibitors (omeprazole)
  • Somatostatin analogues (octreotide)
  • Benzodiazepines (lorazepam)
  • Marijuana, dronabinol
Diarrhea
  • MAC
  • Cryptosporidiosis
  • CMV microsporidiosis
  • Other intestinal infections
  • Malabsorption
  • Medications (eg, protease inhibitors)
  • Specific treatment of disease entities
  • Discontinue offending medication
  • Bismuth, methylcellulose
  • Psyllium
  • Kaolin
  • Diphenoxylate + atropine
  • Loperamide
  • Calcium carbonate
  • Ferrous sulfate
  • Octreotide
  • Tincture of opium
Constipation
  • Dehydration
  • Malignancy
  • Anticholinergic medications
  • Opioids
  • Hydration
  • Radiation and chemotherapy
  • Medication adjustment
  • Activity/diet
  • Prophylaxis for patients taking opioids
  • Peristalsis-stimulating agents:
    • anthracenes (senna)
    • polyphenolics (bisacodyl)
    • Softening agents:
      -surfactant laxatives (docusate)
      -bulk-forming agents (bran, methylcellulose)
      -osmotic laxatives (lactulose, sorbitol)
      -saline laxatives (magnesium hydroxide)
RESPIRATORY
Dyspnea
  • PCP
  • Bacterial pneumonia
  • Anemia
  • Pleural effusion, mass, or obstruction
  • Decreased respiratory muscle function
  • Specific treatment of disease entities
  • Erythropoietin, transfusion
  • Drainage, radiation, or surgery
  • Use of fan, open windows, oxygen
  • Opioids
  • Bronchodilators
  • Methylxanthines
  • Benzodiazepines (eg, lorazepam)
Cough
  • PCP, bacterial pneumonia
  • TB
  • Acid reflux
  • Postnasal drip
  • Specific treatment of disease entities
  • Cough suppressants (dextromethorphan, codeine, other opioids)
  • Decongestants, expectorants (various)
Increased secretions ("death rattle")
  • Fluid shifts
  • Ineffective cough
  • Sepsis
  • Pneumonia
  • Antibiotics as indicated
  • Atropine, hyoscine, transdermal scopolamine, glycopyrrolate
  • Fluid restriction, discontinue intravenous fluids
DERMATOLOGIC
Dry skin
  • Dehydration
  • End-stage renal disease
  • End-stage liver disease
  • Malnutrition medications (eg, indinavir)
  • Hydration
  • Dialysis
  • Nutritional support
  • Discontinue offending medication
  • Emollients with or without salicylates
  • Lubricating ointments or creams (eg, petrolatum, Eucerin)
Pruritus
  • Fungal infection
  • End-stage renal disease
  • End-stage liver disease
  • Dehydration
  • Eosinophilic folliculitis
  • Antifungal agents (itraconazole for eosinophilic folliculitis)
  • Dialysis
  • Hydration
  • Topical corticosteroids
  • Topical agents (menthol, phenol, calamine, doxepin, capsaicin)
  • Antihistamines (doxepin - oral, diphenhydramine)
  • Corticosteroids (topical or systemic)
  • Serotonin antagonists (ondansetron)
  • Opioid antagonists (naloxone, naltrexone)
  • Antidepressants
  • Anxiolytics
  • Neuroleptics
  • Thalidomide
Decubitus ulcers, Pressure sores
  • Poor nutrition
  • Decreased mobility, prolonged bed rest
  • Increase mobility
  • Enhance nutrition
  • Prevention (nutrition, mobility, skin integrity)
  • Wound protection (semipermeable film, hydrocolloid dressing)
  • Debridement (normal saline, enzymatic agents, alginates)
NEUROPSYCHIATRIC
Delirium/agitation
  • Electrolyte imbalances, glucose abnormalities
  • Dehydration
  • Toxoplasmosis
  • Cryptococcal meningitis
  • Sepsis
  • Medication adverse effects (eg, benzodiazepines, opioids, efavirenz)
  • Intoxication
  • Correct imbalances
  • Hydration
  • Specific treatment of disease entities
  • Discontinue offending medications
  • Neuroleptics (haloperidol, risperidone, chlorpromazine)
  • Benzodiazepines (eg, lorazepam, midazolam) (Note: in some patients, these may have adverse effects.)
Dementia
  • AIDS-related dementia
  • Other dementia
  • ART
  • Psychostimulants (methylphenidate)
  • Low-dose neuroleptics (haloperidol)
Depression
  • Chronic illness
  • Reactive depression, major depression
  • Antidepressants (SSRIs, tricyclics, other)
  • Psychostimulants (methylphenidate, pemoline, dextroamphetamine, modafinil)
  • Corticosteroids (prednisone, dexamethasone)

Advance Care Planning

Advance care planning involves planning for future medical care. Two main documents are produced:

  • Advance directive (living will)
  • Health care proxy (a person to speak for the patient or make decisions if the patient is too sick to do so)

The clinician should initiate these conversations and make referrals to helpful resources.

Patient Education

  • Discuss advance care planning with patients, and the option of hospice care, if appropriate.
  • Provide the patient and his or her family with detailed information so that they understand the illness and associated treatments.
  • Instruct patients to discuss their pain or other bothersome symptoms with their health care providers.
  • Encourage patients to talk with their health care providers if they are feeling anxious, depressed, or fearful.
  • Discuss with patients what their death might be like. Some patients may feel relieved to be able to talk openly about their last days. Assure them that their pain will be controlled and that their health care providers will be there to help them.

References

space
space
space

Copyright 2010, the AIDS Education & Training Centers National Resource Center, unless otherwise noted. All rights reserved. Email webmaster@aidsetc.org with questions, comments, or problems. See disclaimer for usage guidelines.